Bridge Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Bridge Advisory’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,662	Closed	-$448K	–	127
2023 Q3	$448K	Buy	3,662 +1,283	+54%	+$163K	0.16%	95
2023 Q2	$302K	Sell	2,379 -111	-4%	-$14.4K	0.11%	103
2023 Q1	$322K	Sell	2,490 -46	-2%	-$6.02K	0.12%	95
2022 Q4	$333K	Sell	2,536 -92	-4%	-$11.9K	0.14%	101
2022 Q3	$307K	Sell	2,628 -224	-8%	-$27.8K	0.15%	89
2022 Q2	$352K	Sell	2,852 -59	-2%	-$7K	0.17%	82
2022 Q1	$379K	Sell	2,911 -635	-18%	-$82.7K	0.17%	73
2021 Q4	$541K	Buy	3,546 +235	+7%	+$36.4K	0.24%	62
2021 Q3	$535K	Buy	3,311 +276	+9%	+$46.4K	0.26%	53
2021 Q2	$497K	Buy	3,035 +1	+0%	+$154	0.25%	53
2021 Q1	$457K	Buy	3,034 +1	+0%	+$159	0.28%	40
2020 Q4	$459K	Buy	+3,033	New	+$433K	0.22%	56

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bridge Advisory's IBB Position: Q4 2023 in Review

Bridge Advisory sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 3,662 shares — an estimated $448K sold.

Bridge Advisory first reported a position in IBB in Q4 2020 and held it in 12 quarters. The position peaked at $541K in Q4 2021. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

Bridge Advisory reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
Bridge Advisory sold 3,662 iShares Biotechnology ETF shares in Q4 2023, an estimated $448K.
Bridge Advisory first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 12 quarters.
Bridge Advisory's iShares Biotechnology ETF position peaked at $541K in Q4 2021.
872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Bridge Advisory's 13F filing for Q4 2023, filed 17 Jan 2024.